Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1055/a-1334-1925 | S2k-Leitlinie – Empfehlungen zur stationären Therapie von Patienten mit COVID-19 |
| https://doi.org/10.1111/j.1365-2516.2006.01416.x | Efficacy, safety and tolerability of recombinant factor VIII (REFACTO®) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria |
| https://doi.org/10.1007/s00101-020-00879-3 | Recommendations for treatment of critically ill patients with COVID-19 |
| https://doi.org/10.1007/s00101-020-00833-3 | Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19 – 3. Version |
| https://doi.org/10.1111/j.1365-2516.2008.01941.x | Haemoassist™– a hand‐held electronic patient diary for haemophilia home care |
| https://doi.org/10.1007/s10405-020-00359-w | Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19 – 3. Version |
| https://doi.org/10.18154/rwth-conv-246988 | Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR) |
| https://doi.org/10.1097/rlu.0000000000003536 | Re: Internal Jugular Vein and Cerebral Venous Sinus Infective Thrombophlebitis Detected With 99mTc-HMPAO White Blood Cell Scintigraphy |
| https://doi.org/10.1111/j.1365-2516.2006.01402.x | Von Willebrand disease within the collective of haemophilic patients as reason for unexpected bleeding episodes |
| https://doi.org/10.1111/j.1365-2516.2004.00949.x | Comparative effectiveness of plasma‐derived and recombinant FVIII concentrates in the on‐demand and prophylactic treatment of patients with haemophilia A |
| https://doi.org/10.4414/smf.2004.05355 | Ursachen und Pathogenese der disseminierten intravasalen Gerinnung (DIC) |
| Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR) Stellungnahme der Ad-hoc-Kommission In-vitro-Diagnostika der AWMF zur Umsetzung der Verordnung (EU) 2017/746 (IVDR) im Hinblick auf In-vitro-Diagnostika aus Eigenherstellung | |
| https://doi.org/10.1055/s-0038-1673672 | GTH News |